These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues. Wang XY, Chen HS, Luo S, Zhang HH, Fei R, Cai J. Oncol Rep; 2009 Mar; 21(3):713-9. PubMed ID: 19212631 [Abstract] [Full Text] [Related]
6. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Li M, Yuan YH, Han Y, Liu YX, Yan L, Wang Y, Gu J. Clin Cancer Res; 2005 Mar 01; 11(5):1809-14. PubMed ID: 15756003 [Abstract] [Full Text] [Related]
8. [Expression of NY-ESO-1/LAGE-1 genes in hepatocellular carcinoma and autologous humoral responses induced thereby]. Xing BC, Yuan YH, Hu ZG, Liu YX, Han Y, Liu N, Chen WF, Wang Y. Zhonghua Yi Xue Za Zhi; 2004 Dec 02; 84(23):1980-2. PubMed ID: 15730810 [Abstract] [Full Text] [Related]
9. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma. Lu Y, Wu LQ, Lü ZH, Wang XJ, Yang JY. Chin Med J (Engl); 2007 Jun 20; 120(12):1042-6. PubMed ID: 17637219 [Abstract] [Full Text] [Related]
10. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma. Nakamura S, Nouso K, Noguchi Y, Higashi T, Ono T, Jungbluth A, Chen YT, Old LJ, Nakayama E, Shiratori Y. J Gastroenterol Hepatol; 2006 Aug 20; 21(8):1281-5. PubMed ID: 16872310 [Abstract] [Full Text] [Related]
11. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma]. Zhang WM, Xiao G, Xie D, Zhang M, Guo AL, Wen JM. Ai Zheng; 2005 May 20; 24(5):622-6. PubMed ID: 15890110 [Abstract] [Full Text] [Related]
14. Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Kurashige T, Noguchi Y, Saika T, Ono T, Nagata Y, Jungbluth A, Ritter G, Chen YT, Stockert E, Tsushima T, Kumon H, Old LJ, Nakayama E. Cancer Res; 2001 Jun 15; 61(12):4671-4. PubMed ID: 11406534 [Abstract] [Full Text] [Related]
16. [Expression of NY-ESO-1 and LAGE-1 cancer-testis antigens in hepatocellular carcinoma]. Zhang WM, Xiao G, Zhang M, Guo AL, Dong Y, Wen JM. Zhonghua Bing Li Xue Za Zhi; 2005 Apr 15; 34(4):202-5. PubMed ID: 16091172 [Abstract] [Full Text] [Related]
17. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Hong JA, Kang Y, Abdullaev Z, Flanagan PT, Pack SD, Fischette MR, Adnani MT, Loukinov DI, Vatolin S, Risinger JI, Custer M, Chen GA, Zhao M, Nguyen DM, Barrett JC, Lobanenkov VV, Schrump DS. Cancer Res; 2005 Sep 01; 65(17):7763-74. PubMed ID: 16140944 [Abstract] [Full Text] [Related]
18. Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer. Wang Y, Wu XJ, Zhao AL, Yuan YH, Chen YT, Jungbluth AA, Gnjatic S, Santiago D, Ritter G, Chen WF, Old LJ, Ji JF. Cancer Immun; 2004 Nov 01; 4():11. PubMed ID: 15516106 [Abstract] [Full Text] [Related]
19. Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy. de Carvalho F, Vettore AL, Inaoka RJ, Karia B, Andrade VC, Gnjatic S, Jungbluth AA, Colleoni GW. Cancer Immun; 2011 Jan 20; 11():1. PubMed ID: 21247062 [Abstract] [Full Text] [Related]
20. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue. Hudolin T, Juretic A, Spagnoli GC, Pasini J, Bandic D, Heberer M, Kosicek M, Cacic M. Prostate; 2006 Jan 01; 66(1):13-8. PubMed ID: 16114059 [Abstract] [Full Text] [Related] Page: [Next] [New Search]